EMAS clinical guide on menopause symptom management in women with dyslipidemias

Dyslipidemias are common and increase the risk of cardiovascular disease. The menopause transition is associated with an atherogenic lipid profile. Published in Maturitas EMAS  has  produced an evidence-based clinical guide evaluating the effects on the lipid profile both of menopausal hormone therapy and of non-estrogen-based treatments for menopausal symptoms. Click here to read more. Menopause…

Message from EMAS

The European Menopause and Andropause Society (EMAS) expresses it sympathy with those affected by the outbreak of COVID-19. We express our solidarity with the medical teams working around the clock to treat and contain the virus. COVID-19 has thankfully caused minimum disruption to the ongoing activities of EMAS. Our Congress is biennial (next edition 2021)…

EMAS and IGCS Position statement on managing the menopause after gynecological cancer

European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position statement on managing the menopause after gynecological cancer Worldwide, 1.3 million new gynecological cancer cases are diagnosed each year. Treatment can result in loss of ovarian function and, in women under the age of 45, early menopause.  This position statement provides an…

EMAS Education

The 2020 edition of EMAS Care Online: The essential guide to women’s health in midlife and beyond is now available to EMAS members. Produced by EMAS,  the book provides  a practical, unbiased and non-promotional international guide for all professionals dealing with menopausal and postmenopausal women. It is accompanied by slide sets to aid teaching and…

Management of depressive symptoms in peri- and post-menopausal women: EMAS Clinical Guide

Amsterdam, 7 November, 2019 – A new position statement by the European Menopause and Andropause Society (EMAS) published in the journal Maturitas summarises the evidence about management of depression at the menopause. Globally, the total number of people with depression exceeds 300 million with a 70% greater incidence in women. The perimenopause is considered to…

EMAS travel award

EMAS travel award EMAS will support the travel costs for junior members who wish to attend international meetings and congresses; or, for example, those who wish to visit laboratories for specific short-term activities, such as collaborative research, or in order to learn new techniques. This is subject to them meeting the assessment criteria for these…

#EMAS2019 in the news

#EMAS2019 in the news Integrating novel scientific insights into clinical application the multidisciplinary international congress was extremely successful and enjoyed by all participants. As part of its menopause week, the BBC filmed speakers on both women’s and men’s health. The clips are below. We look forward to May 2021 when the next congress will be in…